ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

US clearance for key cancer drug provides relief amid regulatory troubles

NEW DELHI (NewsRise) -- Sun Pharmaceutical Industries, India's largest drugmaker, has received approval from the U.S. Food & Drug Administration (FDA) for a generic version of blood cancer drug Gleevec, providing some respite after a string of regulatory issues hit sales in its biggest market -- the United States.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more